Issue 1 · July 19, 2026 · Launch format

Segmentation gets boring, and why that matters

This launch-format issue shows how the Brief will be structured. Replace these sample notes with verified papers, company events, and adoption signals before broad promotion.

Research Worth Reading

Each issue should summarize a small number of papers with a practical clinical lens: sample size, validation quality, workflow relevance, and what the finding would or would not change in practice.

• Tumor segmentation maturity. Track whether studies move beyond Dice scores into time saved, contour correction burden, or treatment-planning integration.
• Spine measurement AI. Separate measurement consistency from evidence that the tool changes decisions or outcomes.
• Foundation models. Watch for neurosurgical validation sets, especially whether spinal cord anatomy is represented rather than inferred from brain or degenerative spine data.

Company And Tool Tracking

The Brief should link back to the Index when a company receives a clearance, launches a product, publishes validation data, raises capital, or shows credible clinical adoption.

Adoption Intelligence

This is the differentiating section: hospital pilots, procurement signals, workflow friction, reimbursement, integration gaps, and places where claims outrun evidence.

Spinal Cord Watch

A standing section for intramedullary tumors, Chiari malformation, syringomyelia, tethered cord, IONM, intraoperative ultrasound, and automated spinal cord measurement. Sparse signals are part of the story: the field is under-covered, and that scarcity is itself useful to track.